Stockholm-based healthtech startup Doctrin raises €10 million to fuel further expansion and AI-development

Doctrin-founders

The Swedish healthtech startup Doctrin raises €10 million in a Series A round led by healthcare provider Capio and Life Science fund HealthCap, with Inbox Capital and Norrsken Foundation as co-investors. The fresh capital enables Doctrin to accelerate expansion in Sweden and internationally, as well as further developing and implementing artificial intelligence in its current products.

Doctrin was founded in 2016 with the purpose to radically improve healthcare through supporting healthcare providers in digitising the patient journey. The company’s digital platform allows healthcare providers to prioritise, treat and follow-up with patients – safe, secure and online. First, the patient describes her symptoms by using a smartphone. When appropriate, treatment is provided through the digital care environment and when required a physical meeting takes place. The results from implementation have proven successful with a 98% patient satisfaction. In addition, patient-physician time is used more efficiently when the physician is provided with a digital summary of the patient’s medical history.

Magnus Liungman, CEO and co-founder of Doctrin, stated: “We have seen that our solutions really work. Our next step is to develop transformative AI-systems to analyse medical images, text and data. This means that health care providers and patients can get recommendations on the kind of care needed, level of urgency as well as diagnosis and treatment.”

In addition to developing intelligent decision support systems, the fresh capital will be used to create solutions within areas other than primary care as well as international expansion.

”As a first step, we are providing 750 000 patients at our 83 primary care units in Sweden with the solutions from Doctrin. This collaboration is one of our most important initiatives to improve the health care for our patients through a unique combination of digital services and the physical care provided by Capio”. says Thomas Berglund, group CEO.

Among the new investors are venture capitalist funds HealthCap, one of Europe’s largest Life Science funds, as well as Inbox Capital. Norrsken Foundation and Capio, both previous investors, also participate in this round.